Cannabis Consortium has Secured a Steady Supply of Medical Grade Oil for its Products

COCONUT CREEK, Fla., Feb. 23, 2018 -- Via OTC PR Wire -- Bahamas Development Corporation (OTC:BDCI) subsidiary company Cannabis Consortium, Inc., has partnered with a Cannabis Distillate to supply all of its Oil needs in California and any other the State the company has operations in.

When Cannabis Consortium rolls out its specialty products, the key factor will be a steady supply of premium oils to be used in its products. The partner chosen by Cannabis Oils has the expertise to assist Cannabis Consortium in creating the right mixture for its various products. The Cannabis Distillate offers a diverse variety of Oils, that combined with Cannabis Consortiums patented delivery method, will provide for desired effects.

About the Cannabis Distillate:

They produce 100% solvent-free cannabis distillate delivering potency, purity and flavor. Their medical grade oil is extracted from micro-grows and is hand trimmed. They use state of the art CO2 Supercritical extraction methods preserving the delicate cannabinoid and full spectrum terpene profile.

About Cannabis Consortium:

Cannabis Consortium is actively pursuing four (4) revenue streams in the cannabis marketplace:

1. Specialty items
2. Beverages
3. Investment
4. Research/New Products

Bahamas Development Corporation, in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg FD.

Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, release of corporate apps, growth of platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.

Details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure on otcmarkets.com.

For additional information about this release please contact:

Investor Relations:

Matt Dwyer
[email protected]
www.cannabisconsortium.net
954-905-9896